ReviewCureus2025
Enhanced Recovery After Surgery in Oesophagogastric Procedures: A Systematic Review of Clinical Outcomes and Postoperative Recovery.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Enhanced Recovery After Surgery (ERAS) programmes have revolutionised perioperative care by integrating evidence-based, multimodal strategies aimed at minimising surgical stress, accelerating recovery, and reducing postoperative morbidity. This systematic review evaluates the impact of ERAS implementation on postoperative morbidity and length of hospital stay (LOS) in patients undergoing oesophagogastric surgery. A comprehensive literature search was conducted across major databases, including PubMed/MEDLINE, Scopus, Web of Science, and Cochrane Central Register of Controlled Trials (CENTRAL), identifying randomised controlled trials (RCTs) published between January 2019 and September 2024. Seven high-quality RCTs involving oesophagectomy and gastrectomy were included for qualitative synthesis. Collectively, these studies demonstrated that ERAS significantly reduced complication rates, particularly pulmonary and gastrointestinal complications, while consistently shortening LOS compared with conventional perioperative care. Some trials further indicated additional benefits such as improved immune modulation, earlier initiation of adjuvant therapy, and enhanced long-term survival outcomes. Mechanistically, ERAS protocols mitigated the physiological stress response, promoted early gastrointestinal motility, and optimised pain control without compromising safety. Despite variations in compliance and protocol standardisation, the evidence supports ERAS as a safe and effective framework for improving short- and long-term postoperative outcomes in upper gastrointestinal surgery. Future studies should focus on personalised ERAS models, compliance auditing, and digital integration to enhance protocol adaptability across diverse healthcare systems.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.